Assessing Impact of Loco-regional Treatment on Survival in Metastatic Breast Cancer at Presentation

NACompletedINTERVENTIONAL

Enrollment

350

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

July 30, 2020

Study Completion Date

July 30, 2020

Conditions

Cancer of the Breast

Interventions

PROCEDURE

Surgery for breast cancer

This group will receive standard loco-regional treatment i.e. surgery (modified radical mastectomy (MRM)/ Simple SMAC/BCT) +/- radiotherapy

OTHER

No Loco-regional treatment

This group will not receive any loco-regional treatment

Trial Locations (1)

Tata Memorial Hospital, Mumbai

All Listed Sponsors

lead

Tata Memorial Hospital

OTHER_GOV

NCT00193778 - Assessing Impact of Loco-regional Treatment on Survival in Metastatic Breast Cancer at Presentation | Biotech Hunter | Biotech Hunter